Coronavirus Patients: Why I Offer Empathetic Care After Nearly Dying
What don’t people know about surviving a stay in the ICU?
Healing does not happen in the hospital. Treatment happens in the hospital. All of the healing happens when you leave. You lose so much muscle mass in the hospital. You lose independence, and for me, even my sense of identity. I also worry a lot about post-traumatic stress disorder (PTSD). For years after my experience, I had nightmares where I was drowning. I had terr… 更多Coronavirus Patients: Why I Offer Empathetic Care After Nearly Dying
What don’t people know about surviving a stay in the ICU?
Healing does not happen in the hospital. Treatment happens in the hospital. All of the healing happens when you leave. You lose so much muscle mass in the hospital. You lose independence, and for me, even my sense of identity. I also worry a lot about post-traumatic stress disorder (PTSD). For years after my experience, I had nightmares where I was drowning. I had terrible, vivid re-experiences of events that, at the time, I didn’t name PTSD, but they probably were. It is almost incalculable, the losses and the process of rebuilding yourself. It really happens on the other side of the hospitalization. People need to rebuild their strength, gain a sense of independence, and find a way to understand what’s happened to them in the construct of their life story.
Could common cardiovascular medications be putting patients at risk of severe COVID-19?
ACE inhibitors and angiotensin receptor blockers are cardiovascular medications commonly used to treat a variety of diseases, including high blood pressure, heart disease, diabetes, and chronic kidney disease. However, early research indicates that these drugs may contribute to an increased risk of severe COVID-19, should patients taking these medications become infected with the novel COVID-19 virus. In a r… 更多Could common cardiovascular medications be putting patients at risk of severe COVID-19?
ACE inhibitors and angiotensin receptor blockers are cardiovascular medications commonly used to treat a variety of diseases, including high blood pressure, heart disease, diabetes, and chronic kidney disease. However, early research indicates that these drugs may contribute to an increased risk of severe COVID-19, should patients taking these medications become infected with the novel COVID-19 virus. In a recent article published in the Journal of Travel Medicine, researchers from the United States hypothesize that the use of ACE inhibitors and angiotensin receptor blockers may be putting these patients at risk of severe COVID-19 and its associated complications.
Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020
On April 8, 2020, this report was posted online as an MMWR Early Release.
shared news